BPTSY
Price
$3.36
Change
+$0.43 (+14.68%)
Updated
Mar 12 closing price
Capitalization
4.55M
BRNS
Price
$0.76
Change
-$0.04 (-5.00%)
Updated
Apr 2 closing price
Capitalization
30.66M
35 days until earnings call
Ad is loading...

BPTSY vs BRNS

Header iconBPTSY vs BRNS Comparison
Open Charts BPTSY vs BRNSBanner chart's image
Biophytis SA
Price$3.36
Change+$0.43 (+14.68%)
Volume$200
Capitalization4.55M
Barinthus Biotherapeutics
Price$0.76
Change-$0.04 (-5.00%)
Volume$47.33K
Capitalization30.66M
BPTSY vs BRNS Comparison Chart
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPTSY vs. BRNS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTSY is a Hold and BRNS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BPTSY: $3.36 vs. BRNS: $0.76)
Brand notoriety: BPTSY and BRNS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPTSY: 25% vs. BRNS: 167%
Market capitalization -- BPTSY: $4.55M vs. BRNS: $30.66M
BPTSY [@Biotechnology] is valued at $4.55M. BRNS’s [@Biotechnology] market capitalization is $30.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPTSY’s FA Score shows that 0 FA rating(s) are green whileBRNS’s FA Score has 1 green FA rating(s).

  • BPTSY’s FA Score: 0 green, 5 red.
  • BRNS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BPTSY and BRNS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 5 TA indicator(s) are bullish.

  • BRNS’s TA Score: 5 bullish, 5 bearish.

Price Growth

BPTSY (@Biotechnology) experienced а 0.00% price change this week, while BRNS (@Biotechnology) price change was -28.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

BRNS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRNS($30.7M) has a higher market cap than BPTSY($4.55M). BPTSY YTD gains are higher at: 8.738 vs. BRNS (-37.086). BPTSY has higher annual earnings (EBITDA): -15.13M vs. BRNS (-52.89M). BRNS has higher revenues than BPTSY: BRNS (15M) vs BPTSY (0).
BPTSYBRNSBPTSY / BRNS
Capitalization4.55M30.7M15%
EBITDA-15.13M-52.89M29%
Gain YTD8.738-37.086-24%
P/E RatioN/AN/A-
Revenue015M-
Total CashN/A106M-
Total DebtN/A12.7M-
TECHNICAL ANALYSIS
Technical Analysis
BRNS
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 29 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 7 days ago
77%
View a ticker or compare two or three
Ad is loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BASE16.470.32
+1.98%
Couchbase
STNE10.730.16
+1.51%
StoneCo Ltd
ONTF5.250.04
+0.77%
ON24
E31.14-0.07
-0.22%
ENI SpA
RAVE2.50-0.08
-3.10%
Rave Restaurant Group

BPTSY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPTSY has been closely correlated with CDTX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if BPTSY jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPTSY
1D Price
Change %
BPTSY100%
N/A
CDTX - BPTSY
92%
Closely correlated
-2.91%
NGNE - BPTSY
38%
Loosely correlated
+8.34%
RNAZ - BPTSY
36%
Loosely correlated
-2.29%
VRCA - BPTSY
27%
Poorly correlated
-0.86%
BRNS - BPTSY
26%
Poorly correlated
-5.55%
More

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-5.55%
SLNO - BRNS
56%
Loosely correlated
+7.93%
NGNE - BRNS
51%
Loosely correlated
+8.34%
NEUP - BRNS
50%
Loosely correlated
+1.75%
IMVT - BRNS
48%
Loosely correlated
+8.03%
TARA - BRNS
35%
Loosely correlated
+6.98%
More